CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

Ophthalmic Surgery Lasers & Imaging Retina is a distinguished journal dedicated to the dissemination of cutting-edge research and clinical advancements in the fields of ophthalmology, surgery, and the application of lasers in retinal care. Published by SLACK INC since its inception in 2013, this journal operates without an open access model, catering primarily to a scholarly audience seeking in-depth and impactful studies. With an impressive impact factor and categorized within the Q2 quartile in respective fields for 2023, it features contributions that significantly enhance the understanding and treatment of ocular diseases. The journal's robust editorial board ensures that only rigorous and innovative research is presented, making it a vital resource for researchers, healthcare professionals, and students who aim to stay at the forefront of ophthalmic surgery and imaging techniques. It continues to forge a path for collaboration and knowledge sharing within the global ophthalmology community.

Expert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

Journal of VitreoRetinal Diseases is a leading publication in the field of ophthalmology, specifically focusing on the complex landscape of vitreo-retinal conditions. Released by SAGE Publications Inc, this journal plays a crucial role in advancing the understanding and treatment of retinal diseases through high-quality, peer-reviewed research. With an ISSN of 2474-1264 and an E-ISSN of 2474-1272, the journal has gained recognition since its inception in 2017, currently ranking in the Q3 category of ophthalmology based on its Scopus metrics. Positioned within the 31st percentile among its peers, the journal provides a platform for the dissemination of innovative findings and clinical practices. Although it operates under a traditional access model, the significance of its contributions is profound, making it an essential resource for researchers, healthcare professionals, and students dedicated to improving patient outcomes in retinal health.

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Taiwan Journal of Ophthalmology is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal has been a vital resource for researchers, practitioners, and students since its inception in 2012. With an ISSN of 2211-5056 and an E-ISSN of 2211-5072, it provides a platform for sharing innovative research, clinical findings, and reviews pertinent to eye health and vision science. The journal is indexed in Scopus and currently holds a Q3 quartile ranking within the ophthalmology category, reflecting its commitment to quality and relevance in the medical community. Located in Mumbai, India, Taiwans Journal of Ophthalmology aims to foster discussions and disseminate knowledge that promotes better understanding and treatment of ocular diseases, ensuring that the latest advancements reach a global audience. By embracing open-access policies, the journal underscores its dedication to making valuable insights readily available to all interested parties, thus contributing significantly to the discourse in ophthalmic research.